Claudia Ordonez - Chief Medical Officer at Keros Therapeutics, Inc.

Issuer-level insider activity

Role
Chief Medical Officer
Issuer ticker
KROS on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Claudia Ordonez since 13 Sep 2025

Reported holdings for Claudia Ordonez in Keros Therapeutics, Inc.

Form 4 holding Chief Medical Officer

Keros Therapeutics, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
98,211
Estimated value
Report date
11 Jun 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Medical Officer

Keros Therapeutics, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
11 Jun 2021
Price
$45.29
Ownership
Direct

Transaction history for Claudia Ordonez in Keros Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .